Childhood craniopharyngioma: Hypothalamus-sparing surgery decreases the risk of obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2376-2382

  Elowe Gruau, E ^a   Beltrand, J ^a,g   Brauner, R ^b,g   Pinto, G ^a   Samara Boustani, D ^a   Thalassinos, C ^a   Busiah, K ^a,g   Laborde, K ^a   Boddaert, N ^a   Zerah, M ^a,g   Alapetite, C ^c   Grill, J ^d   Touraine, P ^e,f   Sainte Rose, C ^a,g   Polak, M ^a,g   Puget, S ^a,g  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Pediatric Endocrinology Unit   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; BRAIN SURGERY; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DISEASE SEVERITY; EXTENSIVE RESECTION SURGERY; FEMALE; FOLLOW UP; FRANCE; GROUPS BY AGE; HUMAN; HYPOTHALAMUS SPARING SURGERY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OBESITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; SCHOOL CHILD; SEX DIFFERENCE; SURGICAL RISK; TEACHING HOSPITAL; WEIGHT GAIN;

BODY MASS INDEX; CHILD; CRANIOPHARYNGIOMA; FEMALE; HUMANS; HYPOTHALAMUS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; OBESITY; PITUITARY NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RISK;

EID: 84878521242     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3928     Document Type: Article

References (39)

1. Brauner R, Malandry F, Rappaport R, Pierre-Kahn A, Hirsch JF. [Craniopharyngioma in children. Endocrine evaluation and treatment. Apropos of 37 cases]. Arch Fr Pediatr. 1987;44:765-769.
2. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007;106:3-12.
3. Muller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96:1981-1991.
4. Pierre-Kahn A, Brauner R, Renier D, Sainte-Rose C, Gangemi MA, Rappaport R. Treatment of craniopharyngiomas in children. Retrospective analysis of 50 cases. Arch Fr Pediatr. 1988;45:163-167.
5. Sahakitrungruang T, Klomchan T, Supornsilchai V, Wacharasindhu S. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr. 2011;170:763-769.
6. Bulow B, Attewell R, Hagmar L, Malmstrom P, Nordstrom CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998;83:3897-3904. (Pubitemid 28513569)
7. Simoneau-Roy J, O'Gorman C, Pencharz P, Adeli K, Daneman D, Hamilton J. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2010;72:364-370.
8. Vinchon M, Weill J, Delestret I, Dhellemmes P. Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst. 2009;25:347-352.
9. Muller HL, Gebhardt U, Etavard-Gorris N, et al. Prognosis and sequela in patients with childhood craniopharyngioma-results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr. 2004;216:343-348. (Pubitemid 39524568)
10. Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J Rare Dis. 2007;2:18.
11. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr. 1982;36:178-184. (Pubitemid 12000248)
12. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991;45:13-21.
13. Czernichow P, Polak M. Testing water regulation. In: Ranke MB, Mullis PE, eds. Diagnostics of Endocrine Function in Children and Adolescents. Basel: Karger; 2011:194-209.
14. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611-616. (Pubitemid 36207799)
15. Gautier A, Godbout A, Grosheny C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab. 2012;97:1258-1267.
16. Trivin C, Busiah K, Mahlaoui N, et al. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr. 2009;9:24.
17. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand. 1988;77:587-592.
18. Villani RM, Tomei G, Bello L, et al. Long-term results of treatment for craniopharyngioma in children. Childs Nerv Syst. 1997;13:397-405. (Pubitemid 27381402)
19. Zuccaro G, Jaimovich R, Mantese B, Monges J. Complications in paediatric craniopharyngioma treatment. Childs Nerv Syst. 1996;12:385-390; discussion 390-391.
20. Sughrue ME, Yang I, Kane AJ, et al. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011;101:463-476.
21. Schubert T, Trippel M, Tacke U, et al. Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst. 2009;25:1419-1427.
22. Muller HL, Gebhardt U, Schroder S, et al. Analyses of treatment variables for patients with childhood craniopharyngioma-results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr. 2010;73:175-180.
23. Bengtsson BA. The consequences of growth hormone deficiency in adults. Acta Endocrinol (Copenh). 1993;128(suppl 2):2-5.
24. Pietila S, Makipernaa A, Sievanen H, Koivisto AM, Wigren T, Lenko HL. Obesity and metabolic changes are common in young childhood brain tumor survivors. Pediatr Blood Cancer. 2009;52:853-859.
25. Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res. 2006;16(suppl A):S41-S48.
26. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89:81-86. (Pubitemid 38183863)
27. Kawamata T, Amano K, Aihara Y. Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Rev. 2010;33:71-81.
28. Caldarelli M, di Rocco C, Papacci F, Colosimo C, Jr. Management of recurrent craniopharyngioma. Acta Neurochir (Wien). 1998;140:447-454. (Pubitemid 28312789)
29. de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R. Obesity in childhood craniopharyngioma: relation to postoperative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab. 1996;81:2734-2737. (Pubitemid 26240304)
30. Muller HL, Bueb K, Bartels U, et al. Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr. 2001;213:244-249. (Pubitemid 32801576)
31. Pierre-Kahn A, Recassens C, Pinto G, et al. Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series. Childs Nerv Syst. 2005;21:817-824. (Pubitemid 41300464)
32. Meuric S, Brauner R, Trivin C, Souberbielle JC, Zerah M, Sainte-Rose C. Influence of tumor location on the presentation and evolution of craniopharyngiomas. J Neurosurg. 2005;103:421-426. (Pubitemid 44968455)
33. Kobayashi T, Kida Y, Mori Y, Hasegawa T. Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg. 2005;103:482-488. (Pubitemid 44954868)
34. Chargari C, Bauduceau O, Bauduceau B, et al. [Craniopharyngiomas: role of radiotherapy]. Bull Cancer. 2007;94:987-994.
35. Merchant TE. Craniopharyngioma radiotherapy: endocrine and cognitive effects. J Pediatr Endocrinol Metab. 2006;19(suppl 1):439-446.
36. Habrand JL, Saran F, Alapetite C, Noel G, El Boustany R, Grill J. Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab. 2006;19(suppl 1):389-394.
37. Luu QT, Loredo LN, Archambeau JO, Yonemoto LT, Slater JM, Slater JD. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 2006;12:155-159.
38. Carmel PW, Antunes JL, Chang CH. Craniopharyngiomas in children. Neurosurgery. 1982;11:382-389. (Pubitemid 12019410)
39. Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990;73:3-11. (Pubitemid 20206377)